Aldeyra Therapeutics (ALDX) News Today

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

$3.98

+0.01 (+0.25%)

(As of 04/18/2024 ET)

Source

Source	Headline
	Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024 businesswire.com - April 18 at 7:00 AM
	Attention Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors: Grabar Law Office Is Investigating Claims on Your Behalf markets.businessinsider.com - April 15 at 8:06 AM
	Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Short Interest Up 12.0% in March marketbeat.com - April 14 at 7:50 AM
	Perceptive advisors buys Aldeyra Therapeutics shares worth $833k investing.com - April 10 at 3:27 PM
	Perceptive Advisors Llc Purchases 37,712 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stock insidertrades.com - April 9 at 4:32 AM
	Perceptive Advisors Llc Buys 37,712 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stock marketbeat.com - April 8 at 6:40 PM
	Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying msn.com - April 4 at 7:45 AM
	Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Major Shareholder Perceptive Advisors Llc Acquires 8,374 Shares insidertrades.com - April 4 at 7:09 AM
	Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Major Shareholder Purchases $27,215.50 in Stock marketbeat.com - April 3 at 6:58 PM
	Aldeyra gains as Oppenheimer upgrades on revised plans for lead asset msn.com - April 3 at 4:44 PM
	Aldeyra's Dry Eye Disease Drug May Be on Path for FDA Approval finance.yahoo.com - April 3 at 4:44 PM
	Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is About To Turn The Corner finance.yahoo.com - April 3 at 8:43 AM
	Aldeyra Therapeutics (NASDAQ:ALDX) Upgraded at Oppenheimer marketbeat.com - April 3 at 8:17 AM
	Analysts Offer Insights on Healthcare Companies: Aldeyra Therapeutics (ALDX), Carisma Therapeutics (CARM) and Panbela Therapeutics (OtherPBLA) markets.businessinsider.com - April 2 at 9:49 AM
	Aldeyra Therapeutics (NASDAQ:ALDX) Stock Rating Reaffirmed by HC Wainwright marketbeat.com - April 2 at 9:12 AM
	Equities Analysts Offer Predictions for Aldeyra Therapeutics, Inc's FY2028 Earnings (NASDAQ:ALDX) marketbeat.com - March 15 at 5:11 AM
	Aldeyra Therapeutics, Inc (NASDAQ:ALDX) to Post Q1 2024 Earnings of ($0.15) Per Share, HC Wainwright Forecasts marketbeat.com - March 14 at 6:40 AM
	Aldeyra Therapeutics Inc President and CEO Todd Brady Sells Company Shares finance.yahoo.com - March 13 at 8:29 AM
	Bruce Greenberg Sells 13,201 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stock insidertrades.com - March 13 at 7:20 AM
	HC Wainwright Comments on Aldeyra Therapeutics, Inc's FY2028 Earnings (NASDAQ:ALDX) marketbeat.com - March 13 at 7:18 AM
	Insider Selling: Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Insider Sells 13,201 Shares of Stock marketbeat.com - March 12 at 10:43 PM
	Q3 2024 Earnings Forecast for Aldeyra Therapeutics, Inc Issued By Leerink Partnrs (NASDAQ:ALDX) marketbeat.com - March 12 at 7:35 AM
	Strong Buy Rating for Aldeyra Therapeutics Backed by Reproxalap Developments and Strategic Partnerships markets.businessinsider.com - March 11 at 12:20 AM
	Institutions own 37% of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares but retail investors control 37% of the company finance.yahoo.com - February 22 at 12:49 PM
	Victory Capital Management Inc. Lowers Holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) marketbeat.com - February 19 at 4:12 AM
	Intellia Therapeutics, Inc. cnn.com - February 14 at 10:59 AM
	Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Crosses Above 50-Day Moving Average of $3.24 marketbeat.com - February 13 at 5:05 AM
	Aldeyra Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference finance.yahoo.com - February 6 at 9:36 AM
	Leerink Partnrs Weighs in on Aldeyra Therapeutics, Inc's FY2024 Earnings (NASDAQ:ALDX) marketbeat.com - January 31 at 7:35 AM
	Aldeyra Therapeutics Stock (NASDAQ:ALDX), Guidance and Forecast benzinga.com - January 31 at 12:40 AM
	Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Expected to Post FY2028 Earnings of $2.55 Per Share marketbeat.com - January 30 at 7:16 AM
	Why Aldeyra Therapeutics Is A Strong Buy: AbbVie Agreement And Reproxalap's Prospects seekingalpha.com - January 28 at 8:41 AM
	Aldeyra Therapeutics (NASDAQ:ALDX) Lowered to "Sell" at StockNews.com marketbeat.com - January 20 at 1:22 AM
	Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Short Interest Update marketbeat.com - January 13 at 8:15 AM
	Grabar Law Office Investigates Claims on Behalf of Shareholders of Aldeyra Therapeutics, Inc. (ALDX) markets.businessinsider.com - January 4 at 6:12 PM
	Aldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in Systemic and Retinal Inflammatory Diseases finance.yahoo.com - January 4 at 8:07 AM
	StockNews.com Downgrades Aldeyra Therapeutics (NASDAQ:ALDX) to Sell marketbeat.com - January 4 at 1:22 AM
	BTIG Reaffirms Their Buy Rating on Aldeyra Therapeutics (ALDX) markets.businessinsider.com - December 31 at 10:39 PM
	Aldeyra Therapeutics (NASDAQ:ALDX) Raised to Hold at StockNews.com marketbeat.com - December 27 at 10:14 PM
	Outperform Rating Affirmed on Aldeyra Therapeutics Following Positive ADX Developments and Expanding Treatment Prospects markets.businessinsider.com - December 21 at 3:06 PM
	Buy Rating Affirmed for Aldeyra Therapeutics Amidst Clinical Advancements and Market Potential markets.businessinsider.com - December 21 at 5:05 AM
	Positive News For Skin Health: Aldeyra Therapeutics' ADX-629 Achieves Key Milestones in Atopic Dermatitis Study msn.com - December 19 at 6:19 PM
	Aldeyra Therapeutics Shares Rise 12% Following Positive Trial Results of ADX-629 marketwatch.com - December 19 at 1:18 PM
	Aldeyra stock jumps 8% on dermatitis drug updates seekingalpha.com - December 19 at 1:18 PM
	Aldeyra Therapeutics' skin disease drug succeeds in mid-stage study reuters.com - December 19 at 8:18 AM
	Aldeyra Therapeutics Announces Statistically and Clinically Significant Improvement from Baseline in Phase 2 Clinical Trial of ADX‑629 in Patients with Atopic Dermatitis finance.yahoo.com - December 19 at 8:18 AM
	Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from Phase 2 Clinical Trial of ADX-629 in Patients with Atopic Dermatitis finance.yahoo.com - December 18 at 8:00 PM
	Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Sees Large Growth in Short Interest marketbeat.com - December 17 at 9:01 AM
	Aldeyra Therapeutics (ALDX) Price Target Increased by 13.56% to 11.39 msn.com - December 16 at 3:23 PM
	Should You Buy Aldeyra Therapeutics (ALDX) Ahead of Earnings? finance.yahoo.com - December 5 at 12:27 PM

Get Aldeyra Therapeutics News Delivered to You Automatically

You’re invited: Biggest crypto event of 2024 (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

ALDX Media Mentions By Week

ALDX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALDX
News Sentiment
▼
0.65

0.53
▲
Average
Medical
News Sentiment

ALDX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALDX Articles
This Week
▼
3

3
▲
ALDX Articles
Average Week

Get Aldeyra Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ALDX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Aldeyra Therapeutics (ALDX) News Today

ALDX Media Mentions By Week

ALDX Media Sentiment

ALDX News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info